The Hawaii Headache & Facial Pain Center has been awarded Hawaii’s first research study investigating a potential preventive treatment for menstrual migraine in women using ubrogepant . Migraine is one of the most common neurological conditions, especially among women. According…
The Hawaii Headache & Facial Pain Center and Hawaii Headache Research Unit have been awarded a clinical research study to investigate XEOMIN® (incobotulinumtoxinA) as a potential preventive treatment for chronic and episodic migraine. This important research initiative aims to address…
